Abbott Laboratories

Abbott Laboratories

92.11
CHF
+1.11
(+1.22%)
143.77BMarket Cap
Jan 27Next Earn

Total Valuation

CHF

As of September 30, 2026, Abbott Laboratories carries a market capitalization of 143.77B, placing it among publicly traded companies globally. Its enterprise value stands at 166.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap143.77B
Enterprise Value166.68B

Important Dates

Abbott Laboratories's next confirmed earnings release is scheduled for January 27, 2027.

Earnings Date1/27/2027

Share Statistics

As of September 30, 2026, Abbott Laboratories has 1.73B shares outstanding.

Shares Outstanding1.73B

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio3.38
P/TBV Ratio-142.77

Financial Position

As of September 30, 2026, Abbott Laboratories maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.45
Quick Ratio1.00
Debt / Equity60.36

Financial Efficiency

These figures cover the twelve months ended September 30, 2026.

Employee Count115,000.00

Taxes

CHF

Over the twelve months ended September 30, 2026, Abbott Laboratories recorded 1.06B in income tax expense.

Income Tax1.06B

Stock Price Statistics

CHF

As of the close on November 12, 2026, Abbott Laboratories's stock has declined approximately 9.36% over the past 52 weeks. The 50-day moving average sits at 87.15, while the 200-day moving average is 86.22.

52-Week Price Change-9.36%
50-Day Moving Average87.15
200-Day Moving Average86.22

Balance Sheet

CHF

As of September 30, 2026, Abbott Laboratories holds 3.59B in cash and equivalents against 26.00B in total debt, resulting in a net debt position of 22.62B. Total book value stands at 42.57B, with working capital of 6.13B providing operational flexibility.

Cash & Cash Equivalents3.59B
Total Debt26.00B
Net Debt22.62B
Equity (Book Value)42.57B
Book Value Per Share24.58
Working Capital6.13B

Cash Flow

CHF

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-1.34B

Dividends & Yields

CHF

Over the twelve months ended September 30, 2026, Abbott Laboratories paid dividends of 1.55 per share.

Dividend Per Share1.55

Stock Splits

Abbott Laboratories's most recent stock split took place on June 1, 1998 with a 1:2 split ratio.

Last Split Date6/1/1998
Split Ratio1:2